Related Experiment Videos
Assessing medication effects in the MTA study using neuropsychological outcomes
Jeffery N Epstein1, C Keith Conners, Aaron S Hervey
1Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. epste002@mc.duke.edu
Summary
Stimulant medication for attention deficit/hyperactivity disorder (ADHD) impacts reaction time (RT) and RT variability. This study found that medication slows RT but reduces variability, highlighting the need for advanced analytical models.
Area of Science:
- Neuroscience
- Child Psychology
- Psychopharmacology
Background:
- Attention deficit/hyperactivity disorder (ADHD) is associated with deficits in reaction time (RT) and RT variability.
- Limited research exists on stimulant medication's effects on these neuropsychological measures in children with ADHD.
Purpose of the Study:
- To investigate the impact of stimulant medication on RT and RT variability in children with ADHD.
- To explore advanced analytical methods for assessing these outcomes.
Main Methods:
- Utilized data from 316 children in the Multimodal Treatment Study of Children with ADHD (MTA).
- Administered the Conners' Continuous Performance Test (CPT) at 24 months.
- Analyzed standard CPT outcomes and Ex-Gaussian distributional model indicators (mu, sigma, tau) for RT.
Main Results:
- Stimulant medication demonstrated significant effects across all neuropsychological outcome measures.
- Ex-Gaussian analysis indicated that stimulant medication slows mean reaction time (RT).
- Stimulant medication was found to reduce RT variability in children with ADHD.
Conclusions:
- Accurate modeling of distributional patterns, including positive skew, is crucial for understanding ADHD.
- Findings provide insights into theoretical models of ADHD and the effects of stimulant treatment.